China's Government Investment, Policies Sustain IVD Market With High Double-digit Growth
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's in vitro diagnostics market was valued at $2 billion in 2009 and is expected to keep a steady pace of 18.5 percent compound annual growth rate in the next three to five years, according to global consulting company Frost & Sullivan